Halobetasol Propionate; Tazarotene Patent Expiration
Halobetasol Propionate; Tazarotene is Used for treating plaque psoriasis in adults. It was first introduced by Bausch Health Americas Inc
Halobetasol Propionate; Tazarotene Patents
Given below is the list of patents protecting Halobetasol Propionate; Tazarotene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Duobrii | US10251895 | Topical compositions and methods for treating psoriasis | Jun 06, 2036 | Bausch |
| Duobrii | US10426787 | Topical compositions and methods for treating psoriasis | Jun 06, 2036 | Bausch |
| Duobrii | US11648256 | Topical compositions and methods for treating psoriasis | Jun 06, 2036 | Bausch |
| Duobrii | US11679115 | Topical compositions and methods for treating psoriasis | Jun 06, 2036 | Bausch |
| Duobrii | US10478502 | Pharmaceutical formulations containing corticosteroids for topical administration | Nov 02, 2031 | Bausch |
| Duobrii | US11839656 | Pharmaceutical formulations containing corticosteroids for topical administration | Nov 02, 2031 | Bausch |
| Duobrii | US11957753 | Pharmaceutical formulations containing corticosteroids for topical administration | Nov 02, 2031 | Bausch |
| Duobrii | US11986527 | Pharmaceutical formulations containing corticosteroids for topical administration | Nov 02, 2031 | Bausch |
| Duobrii | US12076403 | Pharmaceutical formulations containing corticosteroids for topical administration | Nov 02, 2031 | Bausch |
| Duobrii | US8809307 | Pharmaceutical formulations containing corticosteroids for topical administration | Nov 02, 2031 | Bausch |
| Duobrii | US6517847 | Topical gel delivery system |
Aug 03, 2020
(Expired) | Bausch |
Halobetasol Propionate; Tazarotene's Family Patents
Explore Our Curated Drug Screens
Halobetasol Propionate; Tazarotene Generic API Manufacturers
Only one generic application has been filed for Halobetasol Propionate; Tazarotene.
Given below is the list of companies who have filed for Halobetasol Propionate; Tazarotene generic, along with the locations of their manufacturing plants worldwide.
1. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Halobetasol Propionate; Tazarotene. This 0.01%;0.045% version comes by the name HALOBETASOL PROPIONATE AND TAZAROTENE. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.01%; 0.045% | lotion | Prescription | TOPICAL | AB | May 2, 2025 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||